142 related articles for article (PubMed ID: 8452114)
1. Randomized comparison of the antiemetic efficacy of a serotonin type 3 receptor antagonist (MDL 72,222) with a high-dose metoclopramide regimen.
Homesley HD; Hahne WF; McLees B; Heck K; Barrett RJ; Lentz SS; Woodlief L; Lovelace JV
Am J Clin Oncol; 1993 Apr; 16(2):175-9. PubMed ID: 8452114
[TBL] [Abstract][Full Text] [Related]
2. Randomized, double-blind comparison of a prochlorperazine-based versus a metoclopramide-based antiemetic regimen in patients undergoing autologous bone marrow transplantation.
Gilbert CJ; Ohly KV; Rosner G; Peters WP
Cancer; 1995 Dec; 76(11):2330-7. PubMed ID: 8635039
[TBL] [Abstract][Full Text] [Related]
3. Antiemetic control and prevention of side effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. A double-blind, randomized trial.
Kris MG; Gralla RJ; Clark RA; Tyson LB; Groshen S
Cancer; 1987 Dec; 60(11):2816-22. PubMed ID: 3315176
[TBL] [Abstract][Full Text] [Related]
4. Comparison of intermittent ondansetron versus continuous infusion metoclopramide used with standard combination antiemetics in control of acute nausea induced by cisplatin chemotherapy.
Navari RM; Province WS; Perrine GM; Kilgore JR
Cancer; 1993 Jul; 72(2):583-6. PubMed ID: 8319191
[TBL] [Abstract][Full Text] [Related]
5. A single-blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous metoclopramide in the prevention of nausea and vomiting associated with high-dose cisplatin chemotherapy.
Hainsworth J; Harvey W; Pendergrass K; Kasimis B; Oblon D; Monaghan G; Gandara D; Hesketh P; Khojasteh A; Harker G
J Clin Oncol; 1991 May; 9(5):721-8. PubMed ID: 1826739
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the efficacy of tropisetron versus a metoclopramide cocktail based on the intensity of cisplatin-induced emesis.
Chang TC; Hsieh F; Lai CH; Tseng CJ; Cheng HH; Li CL; Michael BJ; Soong YK
Cancer Chemother Pharmacol; 1996; 37(3):279-85. PubMed ID: 8529290
[TBL] [Abstract][Full Text] [Related]
7. A single-dose-finding study of the antiemetic effect and associated plasma levels of MDL 72222 in patients receiving cisplatin.
Logue J; Wilkinson P; Haegele KD; Orwin J
Cancer Chemother Pharmacol; 1991; 27(6):472-6. PubMed ID: 2013117
[TBL] [Abstract][Full Text] [Related]
8. A double-blind, multicentre comparison of intravenous dolasetron mesilate and metoclopramide in the prevention of nausea and vomiting in cancer patients receiving high-dose cisplatin chemotherapy.
Chevallier B; Cappelaere P; Splinter T; Fabbro M; Wendling JL; Cals L; Catimel G; Giovannini M; Khayat D; Bastit P; Claverie N
Support Care Cancer; 1997 Jan; 5(1):22-30. PubMed ID: 9010986
[TBL] [Abstract][Full Text] [Related]
9. Prospective randomized comparison of tropisetron with and without dexamethasone against high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting.
Malik I; Moid I; Khan Z; Hussain M
Am J Clin Oncol; 1999 Apr; 22(2):126-30. PubMed ID: 10199444
[TBL] [Abstract][Full Text] [Related]
10. High-dose metoclopramide + lorazepam versus low-dose metoclopramide + lorazepam + dehydrobenzperidol in the treatment of cisplatin-induced nausea and vomiting.
Herrstedt J; Hannibal J; Hallas J; Andersen E; Laursen LC; Hansen M
Ann Oncol; 1991 Mar; 2(3):223-7. PubMed ID: 2043493
[TBL] [Abstract][Full Text] [Related]
11. The addition of ondansetron to the combination of metoclopramide, dexamethasone, and lorazepam did not improve vomiting prevention in patients receiving high-dose cisplatin.
Baltzer L; Kris MG; Tyson LB; Rigas JR; Pisters KM
Cancer; 1994 Feb; 73(3):720-3. PubMed ID: 8299095
[TBL] [Abstract][Full Text] [Related]
12. Ondansetron + dexamethasone vs metoclopramide + dexamethasone + diphenhydramine in prevention of cisplatin-induced emesis. Italian Group For Antiemetic Research.
Lancet; 1992 Jul; 340(8811):96-9. PubMed ID: 1352024
[TBL] [Abstract][Full Text] [Related]
13. Five-drug antiemetic combination for cisplatin chemotherapy.
Sridhar KS; Hussein AM; Hilsenbeck S; Cairns V
Cancer Invest; 1992; 10(3):191-9. PubMed ID: 1581829
[TBL] [Abstract][Full Text] [Related]
14. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
Sorbe BG
Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
[TBL] [Abstract][Full Text] [Related]
15. Consecutive dose-finding trials adding lorazepam to the combination of metoclopramide plus dexamethasone: improved subjective effectiveness over the combination of diphenhydramine plus metoclopramide plus dexamethasone.
Kris MG; Gralla RJ; Clark RA; Tyson LB; Fiore JJ; Kelsen DP; Groshen S
Cancer Treat Rep; 1985 Nov; 69(11):1257-62. PubMed ID: 3912039
[TBL] [Abstract][Full Text] [Related]
16. An open, randomized study to compare the efficacy and tolerability of tropisetron with that of a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis.
Sorbe B; Hallén C; Frankendal B
Cancer Chemother Pharmacol; 1994; 33(4):298-302. PubMed ID: 8281622
[TBL] [Abstract][Full Text] [Related]
17. Combination antiemetics for cisplatin chemotherapy.
Sridhar KS; Donnelly E
Cancer; 1988 Apr; 61(8):1508-17. PubMed ID: 3280112
[TBL] [Abstract][Full Text] [Related]
18. Double-blind, randomized comparison of the antiemetic efficacy of intravenous dolasetron mesylate and intravenous ondansetron in the prevention of acute cisplatin-induced emesis in patients with cancer. Dolasetron Comparative Chemotherapy-induced Emesis Prevention Group.
Hesketh P; Navari R; Grote T; Gralla R; Hainsworth J; Kris M; Anthony L; Khojasteh A; Tapazoglou E; Benedict C; Hahne W
J Clin Oncol; 1996 Aug; 14(8):2242-9. PubMed ID: 8708713
[TBL] [Abstract][Full Text] [Related]
19. A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis.
Madej G; Krzakowski M; Pawinski A; Lasota W; Rogowski W; Skoneczna I
Semin Oncol; 1994 Oct; 21(5 Suppl 9):3-6. PubMed ID: 9113119
[TBL] [Abstract][Full Text] [Related]
20. [Recent improvements in antiemetic therapy].
Roila F; Palladino MA; Ciccarese G; Basurto C
Tumori; 1997; 83(2 Suppl):S3-14. PubMed ID: 9235727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
